Catalyst Wire Dossier Catalyst Wire Dossier

TSRA-196

· Tessera Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TSRA-196, covering 2025-11-12 to 2025-11-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study of TSRA-196 in Adults With PiZZ Alpha-1 Antitrypsin Deficiency (AATD) [Phase 1, Phase 2]

See pricing